Under construction – not a live service
Sign in
Taking people in United StatesPhase 1

Studying Ketamine's Dissociative Effects in People With Epilepsy

This study examines how ketamine causes dissociative symptoms in adults with epilepsy.

Plain-language title generated from the registry record
Registry title: Understanding Ketamine's Dissociative Effects (KD Study)

Key facts

Where
Palo Alto, United StatesSee the site
Phase
Phase 1

Where in United States

  • Stanford University, School of MedicinePalo Alto, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Stanford University
Trial code
NCT04861051
Record updated
22 April 2026
Original description
The purpose of this study is to understand how ketamine brings about dissociative symptoms.Read full original descriptionShow less

Understanding Ketamine's Dissociative Effects in Epilepsy (KD Study)

The purpose of this study is to understand how ketamine brings about dissociative symptoms.

Inclusion: Patient in Stanford Epilepsy Monitoring Unit; Age >18 years old.

Exclusion: Prior adverse ketamine response; Lifetime psychotic or bipolar disorder; Inability to speak, read or understand English; Pregnant or nursing females.

ClinicalTrials.gov NCT04861051